Swiss Life Sciences at BIO 2025

24 Swiss startups are exhibiting at this year’s BIO International Convention in Boston.

May 28, 2025 | Boston

This June, Swissnex is delighted to welcome to Boston the official Swiss presence at the BIO International Convention, which takes place in the city from June 16 to 19. More than 40 companies and associations will exhibit at the Swiss Pavilion, including 24 startups. The Swiss participants join more than 15,000 biotechnology and pharma leaders who come together for one week of intensive networking, exposing them to the global life science sector and offering them a unique opportunity to discuss potential collaborations.

The Swiss Pavilion is the official Swiss Presence at the conference at the world’s largest global partnering event of the biotech industry. The pavilion is organized by Switzerland Global Enterprise in close collaboration with the Swiss Biotech Association (SBA), the Swiss Business Hub USA, Innosuisse, and Swissnex.

The Swiss startups at BIO 2025 include:

  • cellvie AG | Ischemia / Gene Therapy delivery
  • Enantios | Using Raman optical activity (ROA) technology to characterize complex chiral molecules
  • Limula SA | Automation and Process development service for Cell and Gene Therapy
  • Nagi Bioscience SA | Laboratory Equipment / Drug Discovery / Toxicology / Animal Alternative
  • REM Analytics SA | Microbiome tests / Probiotic QC / Soil testing
  • Synendos Therapeutics AG | Therapeutics / Neuroscience / Clinical Stage / Small Molecule
  • Vandria SA | Therapeutic drugs for the treatment of degenerative / CNS / Muscle diseases
  • Ymmunobio AG | Therapeutic monoclonal antibodies
  • Alithea Genomics | Global leader in scalable transcriptomics solutions for screening applications
  • Bioscibex | Biopharmaceutical equipment / Bioreactor
  • Ceidos SA | Bioprocessing tools
  • Ibex Therapeutics SA | Oral topical therapy to cure and prevent oral mucositis and oral candidiasis
  • ImmunSkills SA | Cancer cell therapy / Biotechnology / Bioprocess
  • Limula SA | Automation and Process development service for Cell and Gene Therapy
  • Ninsun Biotech | Biotechnology / Oncology
  • Novochizol SA | Chitosan nanoparticle-based drug delivery system / Excipients / Implants
  • NXI Therapeutics AG | Coronin 1 modulators / preclinical development / immune-inflammatory conditions
  • Orio Therapeutics | Protein engineering / Regenerative medicine / Cardiovascular
  • PDC Therapeutics | AG Drug delivery / smart nanomedicines / targeted chemotherapy
  • Perseo Pharma | Enzyme therapeutics
  • Polaroid Therapeutics | Advanced Wound Dressings
  • Synendos Therapeutics AG | Therapeutics / Neuroscience / Clinical Stage / Small Molecule
  • Vandria SA | Therapeutic drugs for the treatment of degenerative / CNS / Muscle diseases

Several networking events for Swiss and local stakeholders will be held before and during the convention. On June 12, Swissnex will host the BIO 2025 Pre-Conference Networking event, welcoming members of Boston’s biotech ecosystem to connect with four Swiss startups taking part in the Innosuisse Startup Camps. On June 15, Swissnex will host a welcome reception for the members of the Swiss delegation to the conference. On June 17, Swissnex co-hosts the Swiss Wine & Cheese Reception at the Swiss Pavilion, open to all BIO 2025 attendees.